Stat5 is a prognostic marker for ER-positive breast cancer

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Oncology | 2007年 / 4卷 / 2期
关键词：
D O I：
10.1038/ncponc0701
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：66 / 66
相关论文
共 50 条
  • [1] Moesin is an independent prognostic marker for ER-positive breast cancer
    Yu, Lifeng
    Zhao, Lin
    Wu, Huizhe
    Zhao, Haishan
    Yu, Zhaojin
    He, Miao
    Jin, Feng
    Wei, Minjie
    ONCOLOGY LETTERS, 2019, 17 (02) : 1921 - 1933
  • [2] THE PERCENTAGE OF ER-POSITIVE CELLS IS A SIGNIFICANT PROGNOSTIC MARKER IN BREAST-CANCER
    YOUNES, M
    BROWN, RW
    LABORATORY INVESTIGATION, 1994, 70 (01) : A25 - A25
  • [3] FOXA1 is an independent prognostic marker for ER-positive breast cancer
    Rutika J. Mehta
    Rohit K. Jain
    Samuel Leung
    Jennifer Choo
    Torsten Nielsen
    David Huntsman
    Harikrishna Nakshatri
    Sunil Badve
    Breast Cancer Research and Treatment, 2012, 131 : 881 - 890
  • [4] FOXA1 is an independent prognostic marker for ER-positive breast cancer
    Mehta, Rutika J.
    Jain, Rohit K.
    Leung, Samuel
    Choo, Jennifer
    Nielsen, Torsten
    Huntsman, David
    Nakshatri, Harikrishna
    Badve, Sunil
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (03) : 881 - 890
  • [5] Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
    H R Ali
    S-J Dawson
    F M Blows
    E Provenzano
    P D Pharoah
    C Caldas
    British Journal of Cancer, 2012, 106 : 1798 - 1806
  • [6] Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
    Ali, H. R.
    Dawson, S-J
    Blows, F. M.
    Provenzano, E.
    Pharoah, P. D.
    Caldas, C.
    BRITISH JOURNAL OF CANCER, 2012, 106 (11) : 1798 - 1806
  • [7] The prognostic effects of somatic mutations in ER-positive breast cancer
    Griffith, Obi L.
    Spies, Nicholas C.
    Anurag, Meenakshi
    Griffith, Malachi
    Luo, Jingqin
    Tu, Dongsheng
    Yeo, Belinda
    Kunisaki, Jason
    Miller, Christopher A.
    Krysiak, Kilannin
    Hundal, Jasreet
    Ainscough, Benjamin J.
    Skidmore, Zachary L.
    Campbell, Katie
    Kumar, Runjun
    Fronick, Catrina
    Cook, Lisa
    Snider, Jacqueline E.
    Davies, Sherri
    Kavuri, Shyam M.
    Chang, Eric C.
    Magrini, Vincent
    Larson, David E.
    Fulton, Robert S.
    Liu, Shuzhen
    Leung, Samuel
    Voduc, David
    Bose, Ron
    Dowsett, Mitch
    Wilson, Richard K.
    Nielsen, Torsten O.
    Mardis, Elaine R.
    Ellis, Matthew J.
    NATURE COMMUNICATIONS, 2018, 9
  • [8] The prognostic effects of somatic mutations in ER-positive breast cancer
    Obi L. Griffith
    Nicholas C. Spies
    Meenakshi Anurag
    Malachi Griffith
    Jingqin Luo
    Dongsheng Tu
    Belinda Yeo
    Jason Kunisaki
    Christopher A Miller
    Kilannin Krysiak
    Jasreet Hundal
    Benjamin J Ainscough
    Zachary L. Skidmore
    Katie Campbell
    Runjun Kumar
    Catrina Fronick
    Lisa Cook
    Jacqueline E. Snider
    Sherri Davies
    Shyam M. Kavuri
    Eric C. Chang
    Vincent Magrini
    David E. Larson
    Robert S Fulton
    Shuzhen Liu
    Samuel Leung
    David Voduc
    Ron Bose
    Mitch Dowsett
    Richard K. Wilson
    Torsten O. Nielsen
    Elaine R Mardis
    Matthew J. Ellis
    Nature Communications, 9
  • [9] Prognostic Impact of DLC1 in ER-Positive Breast Cancer
    Gokmen-Polar, Yesim
    Gu, Xiaoping
    Nallamothu, Gouthami
    Badve, Sunil
    MODERN PATHOLOGY, 2015, 28 : 47A - 47A
  • [10] NUDT5 as a novel drug target and prognostic biomarker for ER-positive breast cancer
    Tong, Xin-Yu
    Quan, Yuan
    Zhang, Hong-Yu
    DRUG DISCOVERY TODAY, 2021, 26 (03) : 620 - 625
12345